Steven Cohen Aerie Pharmaceuticals Inc Transaction History

Point72 Asset Management, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.95 - $9.16 $4.74 Million - $8.78 Million	-958,424 Reduced 96.78%	31,900 $239,000
Q1 2022 May 16, 2022	BUY	$5.64 - $9.8 $5.59 Million - $9.71 Million	990,324 New	990,324 $9.01 Million
Q4 2020 Feb 16, 2021	SELL	$9.12 - $14.49 $1.67 Million - $2.66 Million	-183,512 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$10.46 - $14.46 $6.98 Million - $9.64 Million	-666,992 Reduced 78.42%	183,512 $2.16 Million
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $5.35 Million - $7.19 Million	445,914 Added 110.21%	850,504 $12.6 Million
Q1 2020 May 15, 2020	BUY	$11.84 - $25.52 $4.79 Million - $10.3 Million	404,590 New	404,590 $5.46 Million
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $25 Million - $35.5 Million	-1,412,759 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$18.41 - $28.0 $26 Million - $39.6 Million	1,412,759 New	1,412,759 $27.2 Million
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $6.7 Million - $12.2 Million	-203,180 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $1.17 Million - $1.54 Million	20,880 Added 11.45%	203,180 $12.5 Million
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $8.72 Million - $12.8 Million	182,300 New	182,300 $12.3 Million
Q4 2017 Feb 14, 2018	SELL	$50.85 - $65.1 $2.64 Million - $3.38 Million	-51,900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $2.52 Million - $3.12 Million	51,900	51,900 $2.52 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.